stem cell culture
Recently Published Documents


TOTAL DOCUMENTS

423
(FIVE YEARS 80)

H-INDEX

38
(FIVE YEARS 6)

Author(s):  
Kuan-Che Feng ◽  
Juyi Li ◽  
Likun Wang ◽  
Ya-Chen Chuang ◽  
Haijiao Liu ◽  
...  

2021 ◽  
Vol 1 (9) ◽  
Author(s):  
Mishal Ashraf ◽  
Mohammadali Khalilitousi ◽  
Zachary Laksman

Author(s):  
Yuan-Hao Xie ◽  
Chen-Qi Tang ◽  
Zi-Zhan Huang ◽  
Si-Cheng Zhou ◽  
Yu-Wei Yang ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2631
Author(s):  
Neeraj Prabhakar ◽  
Joni Merisaari ◽  
Vadim Le Joncour ◽  
Markus Peurla ◽  
Didem Şen Karaman ◽  
...  

Glioblastoma (GB) is the most frequent malignant tumor originating from the central nervous system. Despite breakthroughs in treatment modalities for other cancer types, GB remains largely irremediable due to the high degree of intratumoral heterogeneity, infiltrative growth, and intrinsic resistance towards multiple treatments. A sub-population of GB cells, glioblastoma stem cells (GSCs), act as a reservoir of cancer-initiating cells and consequently, constitute a significant challenge for successful therapy. In this study, we discovered that PEI surface-functionalized mesoporous silica nanoparticles (PEI-MSNs), without any anti-cancer drug, very potently kill multiple GSC lines cultured in stem cell conditions. Very importantly, PEI-MSNs did not affect the survival of established GB cells, nor other types of cancer cells cultured in serum-containing medium, even at 25 times higher doses. PEI-MSNs did not induce any signs of apoptosis or autophagy. Instead, as a potential explanation for their lethality under stem cell culture conditions, we demonstrate that the internalized PEI-MSNs accumulated inside lysosomes, subsequently causing a rupture of the lysosomal membranes. We also demonstrate blood–brain-barrier (BBB) permeability of the PEI-MSNs in vitro and in vivo. Taking together the recent indications for the vulnerability of GSCs for lysosomal targeting and the lethality of the PEI-MSNs on GSCs cultured under stem cell culture conditions, the results enforce in vivo testing of the therapeutic impact of PEI-functionalized nanoparticles in faithful preclinical GB models.


Sign in / Sign up

Export Citation Format

Share Document